Cyclooxygenase-2 Expression in Non-Small Cell Lung Cancer Correlates With Hypertrophic Osteoarthropathy.


Autoria(s): Rotas I.; Cito G.; Letovanec I.; Christodoulou M.; Perentes J.Y.
Data(s)

2016

Resumo

Hypertrophic osteoarthrpathy (HO) is a rare paraneoplasic syndrome associated with non-small cell lung cancer (NSCLC). The pathophysiology of HO is unknown but was recently related to enhanced levels of urine prostaglandin E2 (PGE2). Here, we report the case of a patient that presented HO in association with a resectable left upper lobe NSCLC. Following surgery and adjuvant chemotherapy, HO resolved and did not recur with development of a brain metastasis 1 year later. Interestingly, tumor cyclooxygenase-2, an enzyme responsible the synthesis of PGE2, was expressed in the primary tumor but not in the resected metastasis.

Identificador

http://serval.unil.ch/?id=serval:BIB_644807C95340

isbn:1552-6259 (Electronic)

pmid:26777972

doi:10.1016/j.athoracsur.2015.09.023

isiid:000368189700007

Idioma(s)

en

Fonte

Annals of Thoracic Surgery, vol. 101, no. 2, pp. e51-e53

Tipo

info:eu-repo/semantics/article

article